These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25874808)

  • 1. The effect of hormone therapy on all-cause and cardiovascular mortality in women with chronic kidney disease: protocol for a systematic review and meta-analysis.
    Ramesh S; Mann MC; Holroyd-Leduc JM; Wilton SB; James MT; Seely EW; Ahmed SB
    Syst Rev; 2015 Apr; 4():44. PubMed ID: 25874808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.
    Dumanski SM; Ramesh S; James MT; Metcalfe A; Nerenberg K; Seely EW; Robertson HL; Ahmed SB
    Syst Rev; 2017 Jul; 6(1):134. PubMed ID: 28683787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis.
    Ramesh S; Mann MC; Holroyd-Leduc JM; Wilton SB; James MT; Seely EW; Ahmed SB
    Menopause; 2016 Sep; 23(9):1028-37. PubMed ID: 27433866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis.
    Upadhyay A; Earley A; Lamont JL; Haynes S; Wanner C; Balk EM
    Ann Intern Med; 2012 Aug; 157(4):251-62. PubMed ID: 22910936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.
    Palmer SC; Hayen A; Macaskill P; Pellegrini F; Craig JC; Elder GJ; Strippoli GF
    JAMA; 2011 Mar; 305(11):1119-27. PubMed ID: 21406649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a protocol for a systematic review and network meta-analysis of primary prevention trials.
    Schwingshackl L; Hoffmann G; Buijsse B; Mittag T; Stelmach-Mardas M; Boeing H; Gottschald M; Dietrich S; Arregui M; Dias S
    Syst Rev; 2015 Mar; 4():34. PubMed ID: 25875487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.
    Badve SV; Palmer SC; Strippoli GFM; Roberts MA; Teixeira-Pinto A; Boudville N; Cass A; Hawley CM; Hiremath SS; Pascoe EM; Perkovic V; Whalley GA; Craig JC; Johnson DW
    Am J Kidney Dis; 2016 Oct; 68(4):554-563. PubMed ID: 27138469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis.
    Palmer SC; Di Micco L; Razavian M; Craig JC; Perkovic V; Pellegrini F; Copetti M; Graziano G; Tognoni G; Jardine M; Webster A; Nicolucci A; Zoungas S; Strippoli GF
    Ann Intern Med; 2012 Mar; 156(6):445-59. PubMed ID: 22431677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map.
    Colombijn JMT; Idema DL; van der Braak K; Spijker R; Meijvis SCA; Bots ML; Hooft L; Verhaar MC; Vernooij RWM
    Syst Rev; 2022 Nov; 11(1):238. PubMed ID: 36371302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of intervention strategies that target arterial stiffness in end-stage renal disease: a systematic review protocol.
    Rodriguez RA; Shea B; Hae R; Burns KD
    Syst Rev; 2016 Jul; 5(1):118. PubMed ID: 27431798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis.
    Sekercioglu N; Busse JW; Sekercioglu MF; Agarwal A; Shaikh S; Lopes LC; Mustafa RA; Guyatt GH; Thabane L
    Ren Fail; 2016 Jul; 38(6):857-74. PubMed ID: 27137817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
    Jamal SA; Vandermeer B; Raggi P; Mendelssohn DC; Chatterley T; Dorgan M; Lok CE; Fitchett D; Tsuyuki RT
    Lancet; 2013 Oct; 382(9900):1268-77. PubMed ID: 23870817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis.
    Ladhani M; Craig JC; Irving M; Clayton PA; Wong G
    Nephrol Dial Transplant; 2017 Mar; 32(3):439-449. PubMed ID: 27190330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies.
    Catalá-López F; Hutton B; Page MJ; Ridao M; Driver JA; Alonso-Arroyo A; Forés-Martos J; Macías Saint-Gerons D; Vieta E; Valencia A; Tabarés-Seisdedos R
    Syst Rev; 2017 Sep; 6(1):189. PubMed ID: 28915839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mineralocorticoid receptor antagonists on left ventricular mass in chronic kidney disease patients: a systematic review and meta-analysis.
    Lu R; Zhang Y; Zhu X; Fan Z; Zhu S; Cui M; Zhang Y; Tang F
    Int Urol Nephrol; 2016 Sep; 48(9):1499-509. PubMed ID: 27193436
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.